LVAC
Income statement / Annual
Last year (2022), LAVA Medtech Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, LAVA Medtech Acquisition Corp.'s net income was $4.50 M.
See LAVA Medtech Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
| General & Administrative Expenses |
$1.30 M
|
$204,237.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.30 M
|
$204,237.00
|
| Other Expenses |
$262,587.00
|
$0.00
|
| Operating Expenses |
$1.56 M
|
$204,237.00
|
| Cost And Expenses |
$1.56 M
|
$204,237.00
|
| Interest Income |
$1.71 M
|
$0.00
|
| Interest Expense |
$0.00
|
-$17.65 M
|
| Depreciation & Amortization |
-$4.66 M
|
$17.65 M
|
| EBITDA |
-$6.22 M |
$17.95 M |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$6.37 M
|
$17.65 M
|
| Income Before Tax |
$4.81 M
|
$17.95 M
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
$304,294.00
|
-$19,152.00
|
| Net Income |
$4.50 M
|
$17.97 M
|
| Net Income Ratio |
0
|
0
|
| EPS |
0.31 |
1.25 |
| EPS Diluted |
0.31 |
1.25 |
| Weighted Average Shares Out |
$14.37 M
|
$14.37 M
|
| Weighted Average Shares Out Diluted |
$14.37 M
|
$14.37 M
|
| Link |
|
|
